![Valerie Kanter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valerie Kanter
Hoofd Techniek/Wetenschap/O&O bij DentaCell Accelerator
Profiel
Valerie Kanter has a current job as the Director, Chief Medical & Scientific Officer at DentaCell Accelerator.
Actieve functies van Valerie Kanter
Bedrijven | Functie | Begin |
---|---|---|
DentaCell Accelerator
![]() DentaCell Accelerator Medical SpecialtiesHealth Technology DentaCell Accelerator is an organization that was converted into an accelerator in 2017 to address innovations in dentistry and support multiple startup launches simultaneously. The company is based in Los Angeles, CA. The company provides access to Leonhardt's Launchpads' building IP estate in stem cell, growth factors, micro pumps, and bioelectric stimulation technologies. The company also offers access to Cal-X Stars Business Accelerator, Inc. network of successful entrepreneurs, investors, mentors, and corporate partners. The company focuses on electroceutical treatment of pseudomonas aeruginosa biofilms. The company was founded in 2014, and the CEO is Howard J. Leonhardt. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
DentaCell Accelerator
![]() DentaCell Accelerator Medical SpecialtiesHealth Technology DentaCell Accelerator is an organization that was converted into an accelerator in 2017 to address innovations in dentistry and support multiple startup launches simultaneously. The company is based in Los Angeles, CA. The company provides access to Leonhardt's Launchpads' building IP estate in stem cell, growth factors, micro pumps, and bioelectric stimulation technologies. The company also offers access to Cal-X Stars Business Accelerator, Inc. network of successful entrepreneurs, investors, mentors, and corporate partners. The company focuses on electroceutical treatment of pseudomonas aeruginosa biofilms. The company was founded in 2014, and the CEO is Howard J. Leonhardt. | Health Technology |